Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Ionis Pharmaceuticals Raises FY2025 Sales Guidance from $825.000M-$850.000M to $875.000M-$900.000M vs $857.588M Est

Author: Benzinga Newsdesk | October 29, 2025 06:03am
Ionis Pharmaceuticals (NASDAQ:IONS) raises FY2025 sales outlook from $825.000 million-$850.000 million to $875.000 million-$900.000 million vs $857.588 million estimate.

Posted In: IONS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist